lobbying_activities: 1304637

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
1304637	a6f661e2-9c25-4731-bcf3-7e6677626fca	Q3	NEW JERSEY HOSPITAL ASSOCIATION	29128	NEW JERSEY HOSPITAL ASSOCIATION	2012	third_quarter	PHA	Support provisions included in S. 3187, the Food and Drug Administration Safety and Innovation Act, which would help speed safe and effective medical products to patients and maintain our nations role as a leader in biomedical innovation. This legislation will drive timely review of new innovator drugs and medical devices, enhance the safety of the drug supply chain in an increasingly globalized market, increase incentives for the development of new antibiotics, renew mechanisms to ensure that childrens medicines are appropriately tested and labeled, and expedite the development and review of certain drugs for the treatment of serious or life-threatening diseases and conditions.	HOUSE OF REPRESENTATIVES,SENATE		70000	0	0	2012-10-17T21:10:40.550000-04:00